Specialty Care Models
Expert articles and analysis related to specialty care models.
AI Summary — Last 7 Days
Specialty VBC momentum this week centered on proving model economics in high-cost conditions: Interwell reported savings and top quality performance in CMMI’s Kidney Care Choices Model, while DaVita’s CKCC progress reinforced investor confidence in integrated kidney care as a scalable risk-bearing specialty platform (Interwell/KCC results). At the same time, specialty models are facing sharper scrutiny on measurement and operations: oncology stakeholders flagged flaws in a key value-based model methodology, dementia care partners are positioning around CMS’ GUIDE Model, and specialists are increasingly framed
Related Articles
Interwell Health delivers savings, top quality scores in Kidney Care Choices Model
Interwell Health delivers savings, top quality scores in Kidney Care Choices Model McKnights Home Care
Synapticure Highlights GUIDE Model Role in Dementia Care for Value-Based Health Partners
Synapticure Highlights GUIDE Model Role in Dementia Care for Value-Based Health Partners TipRanks
DaVita stock gains from integrated kidney care and CKCC progress
DaVita stock gains from integrated kidney care and CKCC progress MSN
DaVita stock gains from integrated kidney care and CKCC progress
DaVita stock gains from integrated kidney care and CKCC progress MSN
Study Finds Flaw in Method for Key Oncology Value-Based Care Model
Study Finds Flaw in Method for Key Oncology Value-Based Care Model AJMC
Study Finds Flaw in Method for Key Oncology Value-Based Care Model
Why Pharmacists Are Central to Closing Care Gaps in the New CKM Syndrome Guideline
Why specialists are the key players in the next phase of value-based care
Why specialists are the key players in the next phase of value-based care Medical Economics